Recombinant mouse perlecan domain I (173 residues) was produced in transfected embryonic kidney cells and purified from the culture medium on DEAE-cellulose. It was shown to be modified by glycosaminoglycans and could be partially separated into two protein pools which were either substituted with heparan sulfate (fragment 1 A) or, to a smaller extent (20%), with chondroitin/dermatan sulfate or a mixture of both glycosaminoglycans (fragment IB). The average molecular mass of the glycosaminoglycans was about 8–10kDa and, thus, smaller than in tissue-derived perlecans. Sequence and carbohydrate analyses localized the heparan sulfate attachment site to three Ser residues within SGD consensus sequences. Furthermore, the N-terminal part of fragment IA contained six Thr/Ser residues substituted by branched galactosamine-containing oligosaccharides and an N-substituted Asn residue. Fragment I was also shown to contain unique immunological epitopes which are not dependent on glycosaminoglycans and are shared by tissue-derived perlecan. Circular dichroism demonstrated a distinct a helix (20%) and β structure (60%) in fragment IA, consistent with predictions of a novel SEA protein module located in the C-terminal part of domain I.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.
- SEA module
a protein module first identified in sperm protein, enterokinase and agrin
Chondroitinase ABC (EC 220.127.116.11)
endoproteinase Asp-N (EC 18.104.22.168)
endoproteinase Glu-C (EC 22.214.171.124)
endoproteinase Lys-C (EC 126.96.36.199)
heparitinase I (EC 188.8.131.52)